Around 250 digital health apps are launching every day, says IQVIAThere was a dramatic increase in the launch of health-related mobile applications last year, taking the total number Share XAround 250 digital health apps are launching every day, says IQVIAhttps://pharmaphorum.com/news/around-250-digital-health-apps-are-launching-per-day-says-iqvia/
Surprise pandemic lessons for pharmaAsk people in most western nations to think back to 2019 and consider what they would have said Share XSurprise pandemic lessons for pharmahttps://deep-dive.pharmaphorum.com/magazine/oncology-2021/surprise-pandemic-lessons-for-pharma/
Designing HCP engagement for the next normalLife sciences companies’ engagement with HCPs has changed significantly in the past 12 months, as the COVID-19 pandemic Share XDesigning HCP engagement for the next normalhttps://pharmaphorum.com/views-and-analysis/designing-hcp-engagement-for-the-next-normal/
Research predicts the post-COVID landscape for HCP engagementIQVIA’s Liz Murray takes us through the company’s latest research into HCPs’ attitudes to pharma engagement, and asks Share XResearch predicts the post-COVID landscape for HCP engagementhttps://deep-dive.pharmaphorum.com/magazine/market-access-2021/research-predicts-the-post-covid-landscape-for-hcp-engagement/
A year on: pandemic driven trends in HCP engagementIQVIA’s John Procter explores why the industry should be paying attention to the changing HCP customer experience in Share XA year on: pandemic driven trends in HCP engagementhttps://deep-dive.pharmaphorum.com/magazine/market-access-2021/a-year-on-pandemic-driven-trends-in-hcp-engagement-customer-experience/
Three pillars of post-pandemic launch excellenceIQVIA’s Sarah Rickwood reviews the launch of innovative medicines in 2020 and outlines three key pillars of activity Share XThree pillars of post-pandemic launch excellencehttps://pharmaphorum.com/views-and-analysis/three-pillars-of-post-pandemic-launch-excellence/
Unlocking health data to improve oncology outcomesAs the largest single-payer healthcare system in Europe, the UK’s National Health Service (NHS) has a uniquely beneficial Share XUnlocking health data to improve oncology outcomeshttps://pharmaphorum.com/r-d/views-analysis-r-d/unlocking-health-data-to-improve-oncology-outcomes-2/
Enabling new models of care: pursuing pharma’s partnership potentialThere is a huge, ongoing shift in how health and wellness is approached in the UK, and the Share XEnabling new models of care: pursuing pharma’s partnership potentialhttps://deep-dive.pharmaphorum.com/magazine/patients-and-partnerships-2020/enabling-new-models-of-care-pursuing-pharmas-partnership-potential/
Nine for 2021: The COVID-19 legacyIn the first of a two part series, IQVIA’s Sarah Rickwood covers nine key trends and events that Share XNine for 2021: The COVID-19 legacyhttps://pharmaphorum.com/views-and-analysis/nine-for-2021-the-covid-19-legacy/
